Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.

Brown TR, Vijarnsorn C, Potts J, Milner R, Sandor GG, Fryer C.

Pediatr Blood Cancer. 2013 May;60(5):842-8. doi: 10.1002/pbc.24404. Epub 2013 Feb 4.

PMID:
23382019
[PubMed - indexed for MEDLINE]
2.

Differences in dose scheduling as a factor in the etiology of anthracycline-induced cardiotoxicity in Ewing sarcoma patients.

Kakadekar AP, Sandor GG, Fryer C, Chan KW, Rogers PC, Pritchard S, Popov R.

Med Pediatr Oncol. 1997 Jan;28(1):22-6.

PMID:
8950332
[PubMed - indexed for MEDLINE]
3.

Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia.

Rathe M, Carlsen NL, Oxhøj H, Nielsen G.

Pediatr Blood Cancer. 2010 Mar;54(3):444-8. doi: 10.1002/pbc.22302.

PMID:
19830828
[PubMed - indexed for MEDLINE]
5.

Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.

Creutzig U, Diekamp S, Zimmermann M, Reinhardt D.

Pediatr Blood Cancer. 2007 Jun 15;48(7):651-62.

PMID:
17183582
[PubMed - indexed for MEDLINE]
6.

Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.

Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B.

J Cancer Surviv. 2012 Mar;6(1):95-101. doi: 10.1007/s11764-011-0186-6. Epub 2011 Jun 1.

PMID:
21630046
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Is there a potential role for serum cardiac troponin I as a marker for myocardial dysfunction in pediatric patients receiving anthracycline-based therapy? A pilot study.

Mathew P, Suarez W, Kip K, Bayar E, Jasty R, Matloub Y, Raisch D.

Cancer Invest. 2001;19(4):352-9.

PMID:
11405175
[PubMed - indexed for MEDLINE]
8.

Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.

Elbl L, Hrstkova H, Tomaskova I, Michalek J.

Support Care Cancer. 2006 Feb;14(2):128-36. Epub 2005 Jul 21.

PMID:
16034614
[PubMed - indexed for MEDLINE]
9.

Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.

Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A.

Health Technol Assess. 2007 Jul;11(27):iii, ix-x, 1-84. Review.

PMID:
17610809
[PubMed - indexed for MEDLINE]
Free Article
10.

Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.

Andolina JR, Dilley K.

J Pediatr Hematol Oncol. 2010 Jul;32(5):411-5. doi: 10.1097/MPH.0b013e3181dccd37.

PMID:
20495481
[PubMed - indexed for MEDLINE]
11.

Anthracycline cardiotoxicity.

Jones RL, Swanton C, Ewer MS.

Expert Opin Drug Saf. 2006 Nov;5(6):791-809. Review.

PMID:
17044806
[PubMed - indexed for MEDLINE]
12.

Cardiac toxicity 4 to 20 years after completing anthracycline therapy.

Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML.

JAMA. 1991 Sep 25;266(12):1672-7.

PMID:
1886191
[PubMed - indexed for MEDLINE]
13.

Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.

Rathe M, Carlsen NL, Oxhøj H.

Pediatr Blood Cancer. 2007 Jun 15;48(7):663-7.

PMID:
17405151
[PubMed - indexed for MEDLINE]
14.

Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines: a longitudinal, prospective exercise echocardiography study.

Guimaraes-Filho FV, Tan DM, Braga JC, Rodrigues A, Waib PH, Matsubara BB.

Pediatr Blood Cancer. 2012 Sep;59(3):548-52.

PMID:
22970439
[PubMed - indexed for MEDLINE]
15.

Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).

Longhi A, Ferrari S, Tamburini A, Luksch R, Fagioli F, Bacci G, Ferrari C.

Cancer. 2012 Oct 15;118(20):5050-9. doi: 10.1002/cncr.27493. Epub 2012 Mar 13.

PMID:
22415578
[PubMed - indexed for MEDLINE]
Free Article
16.

Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.

Sieswerda E, Kremer LC, Vidmar S, De Bruin ML, Smibert E, Sjöberg G, Cheung MM, Weintraub RG.

Pediatr Blood Cancer. 2010 Apr;54(4):579-84. doi: 10.1002/pbc.22371.

PMID:
20014238
[PubMed - indexed for MEDLINE]
17.

Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines.

Guimaraes-Filho F, Tan D, Braga J, Rodrigues A, Waib P, Matsubara B.

Am J Cardiol. 2007 Oct 15;100(8):1303-6. Epub 2007 Aug 13.

PMID:
17920375
[PubMed - indexed for MEDLINE]
18.

N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.

Ekstein S, Nir A, Rein AJ, Perles Z, Bar-Oz B, Salpeter L, Algur N, Weintraub M.

J Pediatr Hematol Oncol. 2007 Jul;29(7):440-4.

PMID:
17609620
[PubMed - indexed for MEDLINE]
19.

Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.

Sherief LM, Kamal AG, Khalek EA, Kamal NM, Soliman AA, Esh AM.

Hematology. 2012 May;17(3):151-6. doi: 10.1179/102453312X13376952196412.

PMID:
22664114
[PubMed - indexed for MEDLINE]
20.

Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients.

Tao HT, Hu Y, Wang JL, Cheng Y, Zhang X, Wang H, Zhang SJ.

Asian Pac J Cancer Prev. 2013;14(5):2967-71.

PMID:
23803063
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk